TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE B-

NCT07503236: Early Feasibility Study (EFS) of the Nyra Cardiac Leaflet Enhancer (CARLEN) System

Sponsor: Nyra Medical, Inc. · Phase: PHASE2 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 30 pts

Competing Trials Overlap

4 Active Trials

Excess Burn Exposure

$730,400

Rescue Site Savings

+$498,000

Unlock Full NCT07503236 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07503236 Rescue Dossier →